Clinical Trials Directory

Trials / Unknown

UnknownNCT05299970

Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women

Effect of Fermented Millet Porridge on Gut Microbiota Diversity and Inflammation Markers in Women of Reproductive Age in Rural Burkina Faso: A Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso · Other Government
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to tackle the problem range from per-pregnancy supplementation to upstream interventions targeting women of reproductive age before conception. To render the latter interventions cost-effective and sustainable, experts recommend to focus on food processing that leads to an enhanced nutrient content. One such method, which has been known and practiced for centuries in diverse societies, is fermentation. Traditionally fermented foods are diverse, widespread and highly appreciated in Burkina Faso. The present study aims to investigate the effect of fermented millet porridge on gut microbiota diversity, stool short chain fatty acid concentration and inflammation markers level in women of reproductive age living in rural Burkina Faso.

Conditions

Interventions

TypeNameDescription
OTHERFermented porridgeA millet porridge (fermented or not, depending on group allocation) serving will be provided to participants daily, for consumption. consumption will be directly observed.

Timeline

Start date
2022-03-21
Primary completion
2024-01-30
Completion
2024-07-31
First posted
2022-03-29
Last updated
2023-10-23

Locations

1 site across 1 country: Burkina Faso

Source: ClinicalTrials.gov record NCT05299970. Inclusion in this directory is not an endorsement.